STAAR Surgical Company (STAA): Price and Financial Metrics


STAAR Surgical Company (STAA): $110.79

-2.24 (-1.98%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

STAA POWR Grades


  • Growth is the dimension where STAA ranks best; there it ranks ahead of 98.16% of US stocks.
  • The strongest trend for STAA is in Growth, which has been heading up over the past 200 days.
  • STAA ranks lowest in Value; there it ranks in the 20th percentile.

STAA Stock Summary

  • STAA's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 662.07 -- higher than 94.34% of US-listed equities with positive expected earnings growth.
  • STAA's current price/earnings ratio is 480.17, which is higher than 98.34% of US stocks with positive earnings.
  • Price to trailing twelve month operating cash flow for STAA is currently 147.7, higher than 96.89% of US stocks with positive operating cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Staar Surgical Co are NIU, MEDP, CLAR, VIAV, and ALRM.
  • Visit STAA's SEC page to see the company's official filings. To visit the company's web site, go to www.staar.com.

STAA Price Target

For more insight on analysts targets of STAA, see our STAA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $138.00 Average Broker Recommendation 1.43 (Moderate Buy)

STAA Stock Price Chart Interactive Chart >

Price chart for STAA

STAA Price/Volume Stats

Current price $110.79 52-week high $139.97
Prev. close $113.03 52-week low $34.41
Day low $107.60 Volume 510,000
Day high $113.84 Avg. volume 731,984
50-day MA $110.54 Dividend yield N/A
200-day MA $83.79 Market Cap 5.20B

STAAR Surgical Company (STAA) Company Bio


STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver lenses into the eye. The company was founded in 1982 and is based in Monrovia, California.


STAA Latest News Stream


Event/Time News Detail
Loading, please wait...

STAA Latest Social Stream


Loading social stream, please wait...

View Full STAA Social Stream

Latest STAA News From Around the Web

Below are the latest news stories about Staar Surgical Co that investors may wish to consider to help them evaluate STAA as an investment opportunity.

STAAR Surgical Company (STAA) CEO Caren Mason on Q1 2021 Results - Earnings Call Transcript

STAAR Surgical Company (STAA) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Brian Moore - Vice President, Investor, Media Relations and Corporate Development Caren Mason - President and Chief Executive Officer Patrick Williams - Chief Financial Officer Conference Call Participants Anthony Petrone - Jefferies Presentation...

SA Transcripts on Seeking Alpha | May 6, 2021

Staar Surgical Co (STAA) Q1 2021 Earnings Call Transcript

At this time, I would like to turn the conference over to Mr. Brian Moore, Vice President, Investor Media Relations and Corporate Development for STAAR Surgical. Thank you for joining us on the STAAR Surgical conference call this afternoon to discuss the Company's financial results for the first quarter ended April 2, 2021.

Yahoo | May 6, 2021

Staar Surgical (STAA) Q1 Earnings and Revenues Beat Estimates

Staar Surgical (STAA) delivered earnings and revenue surprises of 900.00% and 16.67%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 5, 2021

STAAR Surgical Reports Record First Quarter 2021 Net Sales of $50.8 Million Up 44% Y/Y

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the first quarter ended April 2, 2021.

Yahoo | May 5, 2021

STAAR Surgical Co. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 5, 2021 / STAAR Surgical Co. (NASDAQ:STAA) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 4:30 PM Eastern Time.

Yahoo | May 5, 2021

Read More 'STAA' Stories Here

STAA Price Returns

1-mo -2.88%
3-mo -10.43%
6-mo 38.33%
1-year 190.10%
3-year 364.53%
5-year 1,944.10%
YTD 39.85%
2020 125.25%
2019 10.22%
2018 105.87%
2017 42.86%
2016 51.96%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.2791 seconds.